ARCHIVES

Proteomics Used To Find Predictor Of Response In FAP

This article is from The Cancer Letter archive.

Vol. 27 No. 4 | April 30, 2004

Download PDF Visit The Full Archive

Related Articles

Endostatin Enters Phase II Trial For Neuroendocrine Tumors.

December 14, 2001

Schmidt’s Term On Cancer Panel Expires, No Word On Reappointment

February 28, 1975

CT Scan Can Spare Surgery In Head And Neck Cancer

November 25, 2005

Also in this 8-page issue: Amgen names PhRMA executive Rodger Currie vice president for government affairs.

April 30, 2004

CMS Inserts Unprecedented Conditions Into Medicare Coverage of Lung Screening

November 14, 2014

Republican Contenders Slam FDA Decision In Care Of Boy With Treatable Brain Tumor.

February 4, 2000